EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development



Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development



Clinical Cancer Research 8(2): 314-346



Precancer or intraepithelial neoplasia (IEN) is a noninvasive lesion that has genetic abnormalities, loss of cellular control functions, and some phenotypic characteristics of invasive cancer and that predicts for a substantial likelihood of developing invasive cancer. The AACR Task Force on the Treatment and Prevention of IEN has delineated the relationship between IEN and cancer risk as well as the clinical benefit that can be derived from reducing IEN burden. Although several effective endoscopic and surgical treatments for IEN have become standard medical practice, these interventions can confer morbidity and do not treat the entire epithelial field at risk. The incidence of many epithelial cancers is continuing to rise, the number of individuals at risk is increasing with the aging population, and the rapid advancement of imaging and molecular diagnostics is bringing to light precancers that were heretofore clinically silent. There is therefore an urgent need to rapidly develop new treatment and prevention agents for IEN. The AACR IEN Task Force recommends focusing on established precancers as the target for new agent development because of the close association between dysplasia and invasive cancer and because a convincing reduction in IEN burden provides patient benefit by reducing cancer risk and/or by decreasing the need for invasive interventions. The IEN Task Force proposes several clinical trial designs that provide practical and feasible approaches to the rapid development of new agents to treat and prevent precancer.

(PDF 0-2 workdays service: $29.90)

Accession: 035980027

Download citation: RISBibTeXText

PMID: 11839647



Related references

Intraepithelial neoplasia Target for prevention. Journal of Nutrition 133(11S-I): 3850S, November, 2003

Analysis of diagnosis and treatment of vaginal intraepithelial neoplasia and correlation to cervical intraepithelial neoplasia. Zhonghua Fu Chan Ke Za Zhi 44(3): 171-174, 2011

Risk of cervical intraepithelial neoplasia 2+ among women with a history of previous treatment for cervical intraepithelial neoplasia: ASCUS and LSIL Pap smears after treatment. Journal of Lower Genital Tract Disease 15(1): 11-14, 2011

Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia. Urologic Oncology 23(6): 383-385, 2005

DFMO for the treatment or prevention of cervical intraepithelial neoplasia. Official Gazette of the United States Patent & Trademark Office Patents 1241(4), Dec 26, 2000

Identification of chromosomal alterations important in the development of cervical intraepithelial neoplasia and invasive carcinoma using alignment of DNA microarray data. Gynecologic Oncology 103(2): 458-462, 2006

OP25.05: Ultrasound-indicated cerclage for prevention of preterm delivery in primiparas following treatment of cervical intraepithelial neoplasia. Ultrasound in Obstetrics & Gynecology 34(S1): 144-144, 2009

Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clinical Cancer Research 12(12): 3661-3697, 2006

DCIS and LCIS are confusing and outdated terms They should be abandoned inĀ favor of ductal intraepithelial neoplasia DIN and lobular intraepithelial neoplasia LIN. The Breast 22(4): 431-435, 2013

DCIS and LCIS are confusing and outdated terms. They should be abandoned in favor of ductal intraepithelial neoplasia (DIN) and lobular intraepithelial neoplasia (LIN). Breast 22(4): 431-435, 2014

Organ-preserving laser surgery of vulvar intraepithelial neoplasia (VIN) and vaginal intraepithelial neoplasia (VaIN). Chances and limitations. Geburtshilfe und Frauenheilkunde 57(8): 440-446, 1997

Organ-preserving laser surgery of vulvar intraepithelial neoplasia and vaginal intraepithelial neoplasia Chances and limitations. Geburtshilfe und Frauenheilkunde 57(8): 440-446, 1997

High prevalence of papillomavirus-associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia. New England Journal of Medicine 317(15): 916-923, 1987

Misdiagnosis of high-grade vulvar intraepithelial neoplasia (VIN III) as mild cervical intraepithelial neoplasia (CIN I) on Papanicolaou tests. Archives of Pathology & Laboratory Medicine 127(1): 68-70, 2003

Misdiagnosis of high-grade vulvar intraepithelial neoplasia as mild cervical intraepithelial neoplasia on Papanicolaou tests. Archives of Pathology & Laboratory Medicine 127(1): 68-70, January, 2003